T2 Biosystems, Inc. (TTOO)

USD 0.35

(2.88%)

Total Liabilities Summary of T2 Biosystems, Inc.

  • T2 Biosystems, Inc.'s latest annual total liabilities in 2023 was 62.83 Million USD , down -15.5% from previous year.
  • T2 Biosystems, Inc.'s latest quarterly total liabilities in 2024 Q2 was 27.61 Million USD , down -55.83% from previous quarter.
  • T2 Biosystems, Inc. reported annual total liabilities of 74.36 Million USD in 2022, up 1.25% from previous year.
  • T2 Biosystems, Inc. reported annual total liabilities of 73.44 Million USD in 2021, up 4.39% from previous year.
  • T2 Biosystems, Inc. reported quarterly total liabilities of 62.52 Million USD for 2024 Q1, down -0.49% from previous quarter.
  • T2 Biosystems, Inc. reported quarterly total liabilities of 62.83 Million USD for 2023 Q4, up 0.51% from previous quarter.

Annual Total Liabilities Chart of T2 Biosystems, Inc. (2023 - 2012)

Historical Annual Total Liabilities of T2 Biosystems, Inc. (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 62.83 Million USD -15.5%
2022 74.36 Million USD 1.25%
2021 73.44 Million USD 4.39%
2020 70.35 Million USD 12.58%
2019 62.49 Million USD 18.08%
2018 52.92 Million USD -1.12%
2017 53.52 Million USD 6.55%
2016 50.23 Million USD 25.55%
2015 40 Million USD 54.95%
2014 25.82 Million USD -78.74%
2013 121.42 Million USD 63.89%
2012 74.08 Million USD 0.0%

Peer Total Liabilities Comparison of T2 Biosystems, Inc.

Name Total Liabilities Total Liabilities Difference
Bionano Genomics, Inc. 118.24 Million USD 46.863%
Prenetics Global Limited 44.01 Million USD -42.759%
Star Equity Holdings, Inc. 21.67 Million USD -189.887%
CareDx, Inc 223.28 Million USD 71.86%
Exact Sciences Corporation 3.32 Billion USD 98.111%
Exagen Inc. 34.25 Million USD -83.454%
Inotiv, Inc. 588.04 Million USD 89.315%
Guardant Health, Inc. 1.62 Billion USD 96.14%
Biodesix, Inc. 94.51 Million USD 33.521%
BioNexus Gene Lab Corp. 1.74 Million USD -3507.068%
Precipio, Inc. 3.67 Million USD -1611.138%
iSpecimen Inc. 6.07 Million USD -933.767%
Natera, Inc. 691.79 Million USD 90.917%
Aspira Women's Health Inc. 8.62 Million USD -628.33%
Standard BioTools Inc. 159.86 Million USD 60.696%
23andMe Holding Co. 206.64 Million USD 69.594%
Castle Biosciences, Inc. 86.54 Million USD 27.396%
Personalis, Inc. 95.65 Million USD 34.315%
Aclaris Therapeutics, Inc. 40.22 Million USD -56.2%
Applied DNA Sciences, Inc. 8.77 Million USD -615.706%
OpGen, Inc. 13.44 Million USD -367.373%
Myriad Genetics, Inc. 312.9 Million USD 79.919%
ICON Public Limited Company 7.74 Billion USD 99.189%
NeoGenomics, Inc. 739.69 Million USD 91.506%
Star Equity Holdings, Inc. 21.67 Million USD -189.887%
IDEXX Laboratories, Inc. 1.77 Billion USD 96.461%
RadNet, Inc. 2.07 Billion USD 96.969%
MDxHealth SA 121.92 Million USD 48.465%
Psychemedics Corporation 6.59 Million USD -852.304%
Illumina, Inc. 4.36 Billion USD 98.561%
Check-Cap Ltd. 1.33 Million USD -4624.286%
Twist Bioscience Corporation 152.97 Million USD 58.925%
DarioHealth Corp. 38.24 Million USD -64.291%
Fulgent Genetics, Inc. 139.82 Million USD 55.062%
Sera Prognostics, Inc. 25.28 Million USD -148.519%
ENDRA Life Sciences Inc. 1.09 Million USD -5637.351%
OPKO Health, Inc. 622.47 Million USD 89.906%
Medpace Holdings, Inc. 1.09 Billion USD 94.277%
Neogen Corporation 1.44 Billion USD 95.637%
Intelligent Bio Solutions Inc. 5.59 Million USD -1022.886%
Prenetics Global Limited 44.01 Million USD -42.759%
Mainz Biomed B.V. 12.15 Million USD -416.727%
bioAffinity Technologies, Inc. 3.36 Million USD -1766.532%
Trinity Biotech plc 83.38 Million USD 24.646%
Neuronetics, Inc. 81.64 Million USD 23.037%
Sotera Health Company 2.68 Billion USD 97.661%
bioAffinity Technologies, Inc. 3.36 Million USD -1766.532%